HEADER OXIDOREDUCTASE 27-JUN-19 6S4E TITLE STRUCTURE OF HUMAN MTHFD2 IN COMPLEX WITH TH7299 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL METHYLENETETRAHYDROFOLATE COMPND 3 DEHYDROGENASE/CYCLOHYDROLASE, MITOCHONDRIAL; COMPND 4 CHAIN: A; COMPND 5 EC: 1.5.1.15,3.5.4.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MTHFD2, NMDMC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ----, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR R.GUSTAFSSON,E.R.SCALETTI,N.BONAGAS,N.M.GUSTAFSSON,M.HENRIKSSON, AUTHOR 2 E.ABDURAKHMANOV,Y.ANDERSSON,C.BENGTSSON,S.BORHADE,M.DESROSES, AUTHOR 3 K.FARNEGARDH,N.GARG,C.GOKTURK,M.HARALDSSON,P.ILIEV,M.JARVIUS, AUTHOR 4 A.S.JEMTH,C.KALDEREN,S.KARSTEN,F.KLINGEGARD,T.KOOLMEISTER,U.MARTENS, AUTHOR 5 S.LLONA-MINGUEZ,O.LOSEVA,P.MARTTILA,M.MICHEL,R.MOULSON,H.NORDSTROM, AUTHOR 6 C.PAULIN,T.PHAM,L.PUDELKO,A.RASTI,A.K.ROOS,A.SARNO,L.SANDBERG, AUTHOR 7 M.SCOBIE,B.SJOBERG,R.SVENSSON,J.E.UNTERLASS,K.VALLIN,D.VO,E.WIITA, AUTHOR 8 U.WARPMAN-BERGLUND,E.J.HOMAN,T.HELLEDAY,P.STENMARK REVDAT 2 11-MAY-22 6S4E 1 JRNL REVDAT 1 07-JUL-21 6S4E 0 JRNL AUTH N.BONAGAS,N.M.S.GUSTAFSSON,M.HENRIKSSON,P.MARTTILA, JRNL AUTH 2 R.GUSTAFSSON,E.WIITA,S.BORHADE,A.C.GREEN,K.S.A.VALLIN, JRNL AUTH 3 A.SARNO,R.SVENSSON,C.GOKTURK,T.PHAM,A.S.JEMTH,O.LOSEVA, JRNL AUTH 4 V.COOKSON,N.KIWELER,L.SANDBERG,A.RASTI,J.E.UNTERLASS, JRNL AUTH 5 M.HARALDSSON,Y.ANDERSSON,E.R.SCALETTI,C.BENGTSSON, JRNL AUTH 6 C.B.J.PAULIN,K.SANJIV,E.ABDURAKHMANOV,L.PUDELKO,B.KUNZ, JRNL AUTH 7 M.DESROSES,P.ILIEV,K.FARNEGARDH,A.KRAMER,N.GARG,M.MICHEL, JRNL AUTH 8 S.HAGGBLAD,M.JARVIUS,C.KALDEREN,A.B.JENSEN,I.ALMLOF, JRNL AUTH 9 S.KARSTEN,S.M.ZHANG,M.HAGGBLAD,A.ERIKSSON,J.LIU, JRNL AUTH10 B.GLINGHAMMAR,N.NEKHOTIAEVA,F.KLINGEGARD,T.KOOLMEISTER, JRNL AUTH11 U.MARTENS,S.LLONA-MINGUEZ,R.MOULSON,H.NORDSTROM,V.PARROW, JRNL AUTH12 L.DAHLLUND,B.SJOBERG,I.L.VARGAS,D.D.VO,J.WANNBERG,S.KNAPP, JRNL AUTH13 H.E.KROKAN,P.I.ARVIDSSON,M.SCOBIE,J.MEISER,P.STENMARK, JRNL AUTH14 U.W.BERGLUND,E.J.HOMAN,T.HELLEDAY JRNL TITL PHARMACOLOGICAL TARGETING OF MTHFD2 SUPPRESSES ACUTE MYELOID JRNL TITL 2 LEUKEMIA BY INDUCING THYMIDINE DEPLETION AND REPLICATION JRNL TITL 3 STRESS. JRNL REF NAT CANCER V. 3 156 2022 JRNL REFN ESSN 2662-1347 JRNL PMID 35228749 JRNL DOI 10.1038/S43018-022-00331-Y REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0222 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20271 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1076 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1485 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 69 REMARK 3 BIN FREE R VALUE : 0.2560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2215 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.26000 REMARK 3 B22 (A**2) : -0.26000 REMARK 3 B33 (A**2) : 0.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.147 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.139 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.796 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2347 ; 0.014 ; 0.015 REMARK 3 BOND LENGTHS OTHERS (A): 2194 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3193 ; 1.632 ; 1.804 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5134 ; 0.508 ; 1.741 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 290 ; 5.593 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 83 ;36.311 ;21.566 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 370 ;13.998 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;18.684 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 317 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2547 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 375 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1166 ; 1.849 ; 2.506 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1167 ; 1.848 ; 2.509 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1454 ; 2.640 ; 3.736 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1455 ; 2.641 ; 3.740 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1181 ; 3.334 ; 3.146 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1182 ; 3.332 ; 3.147 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1739 ; 5.197 ; 4.548 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2400 ; 7.000 ;31.693 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2401 ; 6.999 ;31.693 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6S4E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1292103110. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21496 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 26.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PHOSPHATE/CITRATE PH 4.3, 42 % REMARK 280 V/V PEG300, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.27950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.27950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.62400 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.27950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.27950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.62400 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 37.27950 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 37.27950 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 49.62400 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 37.27950 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 37.27950 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 49.62400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -90.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 223.67700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 281 REMARK 465 PRO A 282 REMARK 465 VAL A 283 REMARK 465 THR A 284 REMARK 465 ALA A 285 REMARK 465 LYS A 286 REMARK 465 ARG A 333 REMARK 465 LEU A 334 REMARK 465 GLU A 335 REMARK 465 GLU A 336 REMARK 465 ARG A 337 REMARK 465 GLU A 338 REMARK 465 VAL A 339 REMARK 465 LEU A 340 REMARK 465 LYS A 341 REMARK 465 SER A 342 REMARK 465 LYS A 343 REMARK 465 GLU A 344 REMARK 465 LEU A 345 REMARK 465 GLY A 346 REMARK 465 VAL A 347 REMARK 465 ALA A 348 REMARK 465 THR A 349 REMARK 465 ASN A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 205 -69.59 -132.95 REMARK 500 HIS A 232 -168.31 -166.99 REMARK 500 LYS A 301 -36.60 -133.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (2S)-2-[[4-[[2,4-BIS(AZANYL)-6-OXIDANYLIDENE-1H- REMARK 630 PYRIMIDIN-5-YL]CARBAMOYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC REMARK 630 ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 9L9 A 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 9LO GLU REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9L9 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAD A 406 DBREF 6S4E A 36 350 UNP P13995 MTDC_HUMAN 36 350 SEQADV 6S4E MET A 35 UNP P13995 INITIATING METHIONINE SEQRES 1 A 316 MET GLU ALA VAL VAL ILE SER GLY ARG LYS LEU ALA GLN SEQRES 2 A 316 GLN ILE LYS GLN GLU VAL ARG GLN GLU VAL GLU GLU TRP SEQRES 3 A 316 VAL ALA SER GLY ASN LYS ARG PRO HIS LEU SER VAL ILE SEQRES 4 A 316 LEU VAL GLY GLU ASN PRO ALA SER HIS SER TYR VAL LEU SEQRES 5 A 316 ASN LYS THR ARG ALA ALA ALA VAL VAL GLY ILE ASN SER SEQRES 6 A 316 GLU THR ILE MET LYS PRO ALA SER ILE SER GLU GLU GLU SEQRES 7 A 316 LEU LEU ASN LEU ILE ASN LYS LEU ASN ASN ASP ASP ASN SEQRES 8 A 316 VAL ASP GLY LEU LEU VAL GLN LEU PRO LEU PRO GLU HIS SEQRES 9 A 316 ILE ASP GLU ARG ARG ILE CYS ASN ALA VAL SER PRO ASP SEQRES 10 A 316 LYS ASP VAL ASP GLY PHE HIS VAL ILE ASN VAL GLY ARG SEQRES 11 A 316 MET CYS LEU ASP GLN TYR SER MET LEU PRO ALA THR PRO SEQRES 12 A 316 TRP GLY VAL TRP GLU ILE ILE LYS ARG THR GLY ILE PRO SEQRES 13 A 316 THR LEU GLY LYS ASN VAL VAL VAL ALA GLY ARG SER LYS SEQRES 14 A 316 ASN VAL GLY MET PRO ILE ALA MET LEU LEU HIS THR ASP SEQRES 15 A 316 GLY ALA HIS GLU ARG PRO GLY GLY ASP ALA THR VAL THR SEQRES 16 A 316 ILE SER HIS ARG TYR THR PRO LYS GLU GLN LEU LYS LYS SEQRES 17 A 316 HIS THR ILE LEU ALA ASP ILE VAL ILE SER ALA ALA GLY SEQRES 18 A 316 ILE PRO ASN LEU ILE THR ALA ASP MET ILE LYS GLU GLY SEQRES 19 A 316 ALA ALA VAL ILE ASP VAL GLY ILE ASN ARG VAL HIS ASP SEQRES 20 A 316 PRO VAL THR ALA LYS PRO LYS LEU VAL GLY ASP VAL ASP SEQRES 21 A 316 PHE GLU GLY VAL ARG GLN LYS ALA GLY TYR ILE THR PRO SEQRES 22 A 316 VAL PRO GLY GLY VAL GLY PRO MET THR VAL ALA MET LEU SEQRES 23 A 316 MET LYS ASN THR ILE ILE ALA ALA LYS LYS VAL LEU ARG SEQRES 24 A 316 LEU GLU GLU ARG GLU VAL LEU LYS SER LYS GLU LEU GLY SEQRES 25 A 316 VAL ALA THR ASN HET 9L9 A 401 31 HET PO4 A 402 5 HET PO4 A 403 5 HET PO4 A 404 5 HET PO4 A 405 5 HET NAD A 406 44 HETNAM 9L9 (2S)-2-[[4-[[2,4-BIS(AZANYL)-6-OXIDANYLIDENE-1H- HETNAM 2 9L9 PYRIMIDIN-5- HETNAM 3 9L9 YL]CARBAMOYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC HETNAM 4 9L9 ACID HETNAM PO4 PHOSPHATE ION HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 2 9L9 C17 H19 N7 O7 FORMUL 3 PO4 4(O4 P 3-) FORMUL 7 NAD C21 H27 N7 O14 P2 FORMUL 8 HOH *154(H2 O) HELIX 1 AA1 SER A 41 SER A 63 1 23 HELIX 2 AA2 ASN A 78 VAL A 95 1 18 HELIX 3 AA3 SER A 109 ASP A 123 1 15 HELIX 4 AA4 ASP A 140 ASN A 146 1 7 HELIX 5 AA5 HIS A 158 LEU A 167 1 10 HELIX 6 AA6 PRO A 174 GLY A 188 1 15 HELIX 7 AA7 VAL A 205 THR A 215 1 11 HELIX 8 AA8 PRO A 236 ILE A 245 1 10 HELIX 9 AA9 THR A 261 ILE A 265 5 5 HELIX 10 AB1 ASP A 294 ARG A 299 1 6 HELIX 11 AB2 GLY A 311 LYS A 329 1 19 SHEET 1 AA1 6 VAL A 38 VAL A 39 0 SHEET 2 AA1 6 TYR A 304 ILE A 305 1 O ILE A 305 N VAL A 38 SHEET 3 AA1 6 ALA A 270 ASP A 273 1 N VAL A 271 O TYR A 304 SHEET 4 AA1 6 ILE A 249 SER A 252 1 N VAL A 250 O ILE A 272 SHEET 5 AA1 6 ASN A 195 ALA A 199 1 N VAL A 197 O ILE A 251 SHEET 6 AA1 6 THR A 227 SER A 231 1 O THR A 227 N VAL A 196 SHEET 1 AA2 3 ASN A 98 LYS A 104 0 SHEET 2 AA2 3 HIS A 69 VAL A 75 1 N VAL A 72 O ILE A 102 SHEET 3 AA2 3 GLY A 128 VAL A 131 1 O GLY A 128 N SER A 71 SHEET 1 AA3 2 ASN A 277 VAL A 279 0 SHEET 2 AA3 2 LYS A 288 VAL A 290 -1 O LYS A 288 N VAL A 279 CISPEP 1 LEU A 133 PRO A 134 0 3.54 CISPEP 2 VAL A 308 PRO A 309 0 -5.25 SITE 1 AC1 23 SER A 83 TYR A 84 ASN A 87 LYS A 88 SITE 2 AC1 23 VAL A 131 GLN A 132 LEU A 133 ASP A 155 SITE 3 AC1 23 PHE A 157 ILE A 276 ARG A 278 LEU A 289 SITE 4 AC1 23 PRO A 309 GLY A 310 GLY A 313 PRO A 314 SITE 5 AC1 23 NAD A 406 HOH A 517 HOH A 525 HOH A 544 SITE 6 AC1 23 HOH A 571 HOH A 585 HOH A 587 SITE 1 AC2 5 ARG A 201 ARG A 233 NAD A 406 HOH A 563 SITE 2 AC2 5 HOH A 564 SITE 1 AC3 5 ARG A 90 LEU A 167 ASP A 168 HIS A 219 SITE 2 AC3 5 GLU A 220 SITE 1 AC4 4 LEU A 173 TRP A 181 ARG A 221 PRO A 222 SITE 1 AC5 3 ILE A 160 ARG A 164 HOH A 501 SITE 1 AC6 23 THR A 176 ARG A 201 SER A 202 ASN A 204 SITE 2 AC6 23 VAL A 205 HIS A 232 ARG A 233 ALA A 253 SITE 3 AC6 23 ALA A 254 GLY A 255 ILE A 256 VAL A 274 SITE 4 AC6 23 GLY A 275 ILE A 276 ASN A 277 THR A 316 SITE 5 AC6 23 9L9 A 401 PO4 A 402 HOH A 512 HOH A 538 SITE 6 AC6 23 HOH A 544 HOH A 557 HOH A 563 CRYST1 74.559 74.559 99.248 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013412 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013412 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010076 0.00000